• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.69% Nasdaq Down1.07%

    More On CIPLA.NS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Cipla Limited (CIPLA.NS)

    -NSE
    682.15 Up 22.30(3.38%) 5:59AM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Cipla Limited
    Cipla House
    Peninsula Business Park
    Mumbai, 400013
    India - Map
    Phone: 91 22 2482 6000
    Website: http://www.cipla.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Major
    Full Time Employees:N/A

    Business Summary 

    Cipla Limited manufactures and sells pharmaceutical and personal care products in India. It offers active pharmaceutical ingredients; and formulations in therapeutic areas, such as allergy, analgesic, anti-malarial, anti-infectives, cardiology, dermatology and cosmeceuticals, diabetology, gastroenterology, HIV-AIDS, hormones and steroids, iron chelators, musculoskeletal, neuropsychiatry, oncology, respiratory, urology, and womenÂ’s health, as well as nutritional and ophthalmic products. The company also provides veterinary products for various animals, including companion, equine, general care, livestock, and poultry. In addition, it offers inhaled medication and devices comprising dry powder inhalers, metered-dose inhalers, spacers and related devices, nasal sprays, nebulizers, and inhalation accessory devices. The company also exports raw materials, intermediates, prescription drugs, over-the-counter drugs, and veterinary products to approximately 170 countries worldwide. Cipla Limited was founded in 1935 and is based in Mumbai, India.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Cipla Limited

    Key Executives 
     PayExercised
    Mr. Subhanu Saxena , 50
    Global Chief Exec. Officer, Managing Director, Director, Chairman of Risk Management Committee, Chairman of Mergers & Acquisitions Committee and Member of Corp. Social Responsibility Committee
    133.08MN/A
    Mr. Mital Sanghvi ,
    Chief Compliance Officer and Company Sec.
    9.90MN/A
    Mr. S. Radhakrishnan CA,
    Whole-Time Director, Member of Mergers & Acquisitions Committee, Member of Audit Committee, Member of Stakeholders Relationship Committee, Member of Corp. Social Responsibility Committee and Member of Risk Management Committee
    36.87MN/A
    Mr. Davinder Singh ,
    Exec.
    N/AN/A
    Mrs. Geena V. Malhotra ,
    Exec.
    N/AN/A
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in INR.